{"id":"W4283780799","doi":"10.1016/j.annonc.2022.04.117","title":"P-26 HERIZON-GEA-01: A phase 3 study of zanidatamab in combination with chemotherapy with or without tislelizumab in first-line human epidermal growth factor receptor 2 positive (HER2+) advanced/metastatic gastroesophageal adenocarcinoma (GEA)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Antibody-dependent cell-mediated cytotoxicity; Chemotherapy; Cancer; Regimen; Cancer research; Oncology; Chemotherapy regimen; Combination chemotherapy; Internal medicine; Monoclonal antibody; Antibody; Immunology; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003809888,0.0003032092,0.001191425,0.0005620325,0.00008530381,0.000007124673,0.0002265277,0.00004636014,0.0006478609],"category_scores_gemma":[0.0000467657,0.0002413062,0.00006487557,0.0008657778,0.0001424083,0.0001975439,0.0001085584,0.0003673292,0.000001476336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002532931,"about_ca_system_score_gemma":0.0002428952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007645862,"about_ca_topic_score_gemma":0.002123165,"domain_scores_codex":[0.9975101,0.0002896479,0.0007590041,0.0004774393,0.0005212344,0.0004425957],"domain_scores_gemma":[0.9986269,0.0001712792,0.0006084325,0.0003114773,0.0001849677,0.00009696198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04958878,0.02151309,0.883252,0.0003600629,0.0006419778,0.001433023,0.008434973,0.0002755523,0.0005292207,0.00007426773,0.0006212262,0.03327588],"study_design_scores_gemma":[0.08783405,0.1787924,0.7244316,0.0001227295,0.0001554295,0.0001044895,0.006900671,0.0001914839,0.0009363621,0.00003438147,0.0002565695,0.0002398349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994658,0.0001191891,0.0001264241,0.002470332,0.00005790746,0.002295962,0.00007445511,0.0000302802,0.000167435],"genre_scores_gemma":[0.9976258,0.00005812219,0.001040093,0.0005838699,0.00003000741,0.0002739509,0.0001263482,0.00005662674,0.0002051608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1588204,"threshold_uncertainty_score":0.9840182,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0511468960694192,"score_gpt":0.3694295074956583,"score_spread":0.3182826114262391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}